Real-time enrollment status for this hidradenitis suppurativa clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 11:34 AM UTC
| NCT Number | NCT07244263 |
| Recruiting Status | Recruiting |
| Condition | Hidradenitis Suppurativa |
| Phase | PHASE2 |
| Target Enrollment | 90 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Takeda |
| Last Updated on CT.gov | March 6, 2026 (Mar 6, 2026) |
As of August 27, 2026: Clinical trial NCT07244263 is currently recruiting participants. This phase2 study for hidradenitis suppurativa is actively seeking new participants at 15 locations across the United States. The study is sponsored by Takeda. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07244263 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07244263 was last updated Mar 6, 2026 (March 6, 2026). HelloStudys verifies this status automatically.